8-K - MAIA Biotechnology, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On February 24, 2026, MAIA Biotechnology, Inc. (the “Company”) issued a 2026 Letter to Shareholders detailing the Company’s development pipeline.

Other Event

$50.00B

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 2026 Letter to Shareholders 99.2 Press Release dated February 24, 2026 104 Cover P

Exhibits Only

Source Document

Exhibits (3)

8-K

99.1

EX-99.1

99.2

EX-99.2